Loading...
XJPX4368
Market cap747mUSD
Jan 15, Last price  
3,310.00JPY
1D
-0.90%
1Q
-13.24%
Jan 2017
31.82%
Name

Fuso Chemical Co Ltd

Chart & Performance

D1W1MN
XJPX:4368 chart
P/E
13.99
P/S
1.98
EPS
236.64
Div Yield, %
1.99%
Shrs. gr., 5y
-0.14%
Rev. gr., 5y
6.98%
Revenues
58.97b
-13.86%
21,736,215,00024,463,239,00027,059,879,00030,833,544,00030,077,903,00029,798,417,00030,251,938,00028,247,878,00027,355,263,00029,327,471,00032,223,525,00035,298,629,00036,224,356,00040,221,619,00042,074,721,00041,310,689,00042,209,380,00055,760,482,00068,459,392,00058,970,273,000
Net income
8.34b
-40.95%
1,252,723,0001,381,610,0001,409,907,0001,760,763,000209,636,0001,435,086,0002,331,386,0002,508,189,0001,903,668,0002,258,554,0003,452,058,0004,716,121,0006,895,594,0006,592,287,0006,881,266,0007,014,323,0006,808,079,00010,890,394,00014,129,459,0008,343,299,000
CFO
7.06b
-49.29%
224,082,0001,005,849,0002,859,380,0003,878,081,0001,748,283,0007,007,945,0005,321,184,0001,838,731,0004,266,589,0003,573,386,0006,369,454,0008,086,532,0009,413,515,0004,845,599,0008,148,493,00011,936,908,00012,820,551,00010,199,062,00013,925,984,0007,061,380,000
Dividend
Mar 28, 20250 JPY/sh

Profile

Fuso Chemical Co.,Ltd. manufactures and sells life science, electronic material, and functional chemical products worldwide. Its life science products include malic acid and derivatives, citric acid and derivatives, L-tartaric acid and derivatives, lactic acid and derivatives, gluconic acid and derivatives, other acid derivatives, ascorbic and isoascorbic acids, and amino acid and derivatives, as well as water soluble rust proof agents/water soluble grinding and cutting fluids. The company's electronic material products comprise ultra-high purity colloidal silica and high purity organo silica sol; and functional chemical products that consist of oxidation and reduction products, as well as benzoic acid derivatives. It also exports its products. Fuso Chemical Co.,Ltd. was founded in 1952 and is headquartered in Osaka, Japan.
URL
https://fusokk.co.jp/
IPO date
May 30, 2001
Employees
859
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
58,970,273
-13.86%
68,459,392
22.77%
55,760,482
32.10%
Cost of revenue
48,736,000
50,373,359
41,413,133
Unusual Expense (Income)
NOPBT
10,234,273
18,086,033
14,347,349
NOPBT Margin
17.35%
26.42%
25.73%
Operating Taxes
3,662,894
5,952,861
4,823,517
Tax Rate
35.79%
32.91%
33.62%
NOPAT
6,571,379
12,133,172
9,523,832
Net income
8,343,299
-40.95%
14,129,459
29.74%
10,890,394
59.96%
Dividends
(2,325,355)
(2,114,417)
(1,768,811)
Dividend yield
1.43%
1.59%
1.11%
Proceeds from repurchase of equity
(744)
9,918
(1,101,965)
BB yield
0.00%
-0.01%
0.69%
Debt
Debt current
9,938
6,398
Long-term debt
20,006,580
14,881
13,375
Deferred revenue
Other long-term liabilities
1,959,611
1,926,189
1,851,567
Net debt
(12,350,851)
(24,750,767)
(26,166,456)
Cash flow
Cash from operating activities
7,061,380
13,925,984
10,199,062
CAPEX
(14,945,000)
(13,634,807)
(9,621,672)
Cash from investing activities
(18,576,343)
(13,417,624)
(9,375,030)
Cash from financing activities
17,663,842
(2,124,635)
(2,882,427)
FCF
(11,635,180)
(1,853,502)
(1,305,375)
Balance
Cash
31,471,999
23,412,586
24,360,229
Long term investments
885,432
1,363,000
1,826,000
Excess cash
29,408,917
21,352,616
23,398,205
Stockholders' equity
86,522,197
83,794,812
71,595,185
Invested Capital
87,575,710
64,784,485
50,543,322
ROIC
8.63%
21.04%
20.77%
ROCE
8.73%
20.95%
19.35%
EV
Common stock shares outstanding
35,247
35,244
35,348
Price
4,605.00
22.31%
3,765.00
-16.52%
4,510.00
10.95%
Market cap
162,314,042
22.32%
132,692,034
-16.77%
159,420,856
10.46%
EV
149,963,191
107,941,267
133,254,400
EBITDA
17,394,437
22,423,591
18,800,748
EV/EBITDA
8.62
4.81
7.09
Interest
121,678
16,913
Interest/NOPBT
1.19%
0.12%